USING FLOW DIVERTING STENT FOR UNRUPTURED INTRACRANIAL VERTEBRAL ARTERY FUSIFORM ANEURYSM

Thanh Dũng Lê1,2,3,, Xuân Hải Đào 1,3
1 Viet Duc hospital
2 VNU Hanoi-University of Medicine and Pharmacy
3 HMU

Main Article Content

Abstract

Objectives: This study aims to evaluate the effectiveness and share some of our experiences treating intracranial vertebral artery fusiform aneurysms (IVAFA) using flow diverting stents (FDS). Subjects and methods: Retrospective study on 10 patients with IVAFA treated with FDS at Viet Duc University Hospital from January 2020 to December 2022, with a minimum follow-up time of 6 months. Clinical features, images, and data on the procedure and outcomes were collected. Results: A total of 10 patients (9 male, 1 female, with a mean age of 48.9 ± 6.5 years) were included in the study. All patients were treated using a single stent. Complete occlusion was achieved in all patients after 6 months, and significantly improved symptoms compared with before intervention. The mean mRs score before the intervention was 1.2 points compared to 1.1 after. Major complications occurred in 2 patients (1 case died from an intracerebral hemorrhage related to antiplatelet drugs, 1 case of cerebral infarction due to occlusion of bilateral posterior inferior cerebellar artery). Minor complications were observed in 2 patients (1 asymptomatic stent occlusion and 1 asymptomatic post-stent vertebral artery stenosis). Conclusion: Flow diversion is an effective method in treating IVAFA, but there is always potential for early or late acute complications, so there must be adherence to diligent patient selection and procedural and periprocedural nuances. 

Article Details

References

1. Li W, Zhu W, Wang Y, et al. Stent-alone treatment of unruptured vertebral artery fusiform aneurysms: A comparison of flow diverter and conventional stents. Frontiers in Neurology. 2022;13. Accessed February 19, 2023. https://www.frontiersin.org/articles/10.3389/fneur.2022.1012382
2. Alderazi YJ, Shastri D, Kass-Hout T, Prestigiacomo CJ, Gandhi CD. Flow Diverters for Intracranial Aneurysms. Stroke Research and Treatment. 2014;2014:e415653. doi:10.1155/ 2014/415653
3. Awad AJ, Mascitelli JR, Haroun RR, Leacy RAD, Fifi JT, Mocco J. Endovascular management of fusiform aneurysms in the posterior circulation: the era of flow diversion. Neurosurgical Focus. 2017;42(6):E14. doi:10.3171/2017.3.FOCUS1748
4. Monteith SJ, Tsimpas A, Dumont AS, et al. Endovascular treatment of fusiform cerebral aneurysms with the Pipeline Embolization Device. J Neurosurg. 2014;120(4):945-954. doi:10.3171/ 2013.12.JNS13945
5. Broderick JP, Adeoye O, Elm J. The Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials. Stroke. 2017;48(7):2007-2012. doi:10.1161/STROKEAHA.117.017866
6. Corley JA, Zomorodi A, Gonzalez LF. Treatment of Dissecting Distal Vertebral Artery (V4) Aneurysms With Flow Diverters. Oper Neurosurg (Hagerstown). 2018;15(1):1-9. doi:10.1093/ ons/opx180
7. Waqas M, Dossani RH, Alkhaldi M, et al. Flow redirection endoluminal device (FRED) for treatment of intracranial aneurysms: A systematic review. Interv Neuroradiol. 2022;28(3):347-357. doi:10.1177/15910199211027991
8. Flemming KD, Wiebers DO, Brown RD, et al. The natural history of radiographically defined vertebrobasilar nonsaccular intracranial aneurysms. Cerebrovasc Dis. 2005;20(4):270-279. doi: 10.1159/000087710
9. Natarajan SK, Lin N, Sonig A, et al. The safety of Pipeline flow diversion in fusiform vertebrobasilar aneurysms: a consecutive case series with longer-term follow-up from a single US center. J Neurosurg. 2016;125(1):111-119. doi:10.3171/2015.6.JNS1565